1.The Impact of the Amount of Rehabilitation Provision on Functional Outcome in Vertebral Compression Fractures
Yoshie SUZUKI ; Miho SHIMIZU ; Yuki KATO ; Ryo MOMOSAKI
The Japanese Journal of Rehabilitation Medicine 2025;():23063-
Introduction: Patients with vertebral compression fractures are likely to decrease physical function and activities of daily living (ADL) due to pain and inactivity. In this study, we examined the effect of the amount of rehabilitation provided on functional prognosis in patients with vertebral compression fracture.Methods: We included 18,174 vertebral compression fracture patients aged 65 years or older in the JMDC multicenter data. Barthel index (BI) gains, BI efficiency, ADL independence at discharge (BI≧95), and discharge home were compared between patients who received an average of at least 1 unit of rehabilitation during hospitalization (high-provider group) and those who received less than 1 unit per day (low-provider group).Results: There were 4,145 patients in the high-provider group and 14,029 in the low-provider group. The high-provider group had higher BI gain and BI efficiency, as well as a higher percentage of patients with independent ADLs at discharge (41.6%) and a higher percentage of patients discharged home (79.2%). In multiple regression analysis, the high-provider group had higher BI gain (regression coefficient: 2.423)and BI efficiency (regression coefficient: 0.043). Multiple logistic regression analysis showed that the high-provider group had a higher rate of discharge home (odds ratio:1.26) and a higher rate of ADL independence at discharge (odds ratio: 1.17).Conclusion: In patients with vertebral compression fractures, the amount of rehabilitation provision may have an impact on functional prognosis.
2.Effectiveness of a novel ex vivo training model for gastric endoscopic submucosal dissection training: a prospective observational study conducted at a single center in Japan
Takahito TOBA ; Tsuyoshi ISHII ; Nobuyuki SATO ; Akira NOGAMI ; Aya HOJO ; Ryo SHIMIZU ; Ai FUJIMOTO ; Takahisa MATSUDA
Clinical Endoscopy 2025;58(1):94-101
Background/Aims:
The efficacy of endoscopic submucosal dissection (ESD) for early-stage gastric cancer is well established. However, its acquisition is challenging owing to its complexity. In Japan, G-Master is a novel ex vivo gastric ESD training model. The effectiveness of training using G-Master is unknown. This study evaluated the efficacy of gastric ESD training using the G-Master to evaluate trainees’ learning curves and performance.
Methods:
Four trainees completed 30 ESD training sessions using the G-Master, and procedure time, resection area, resection completion, en-bloc resection requirement, and perforation occurrence were measured. Resection speed was the primary endpoint, and learning curves were evaluated using the Cumulative Sum (CUSUM) method.
Results:
All trainees completed the resection and en-bloc resection of the lesion without any intraoperative perforations. The learning curves covered three phases: initial growth, plateau, and late growth. The transition from phase 1 to phase 2 required a median of 10 sessions. Each trainee completed 30 training sessions in approximately 4 months.
Conclusions
Gastric ESD training using the G-Master is a simple, fast, and effective method for pre-ESD training in clinical practice. It is recommended that at least 10 training sessions be conducted.
3.The Impact of the Amount of Rehabilitation Provision on Functional Outcome in Vertebral Compression Fractures
Yoshie SUZUKI ; Miho SHIMIZU ; Yuki KATO ; Ryo MOMOSAKI
The Japanese Journal of Rehabilitation Medicine 2025;62(2):182-188
Introduction: Patients with vertebral compression fractures are likely to decrease physical function and activities of daily living (ADL) due to pain and inactivity. In this study, we examined the effect of the amount of rehabilitation provided on functional prognosis in patients with vertebral compression fracture.Methods: We included 18,174 vertebral compression fracture patients aged 65 years or older in the JMDC multicenter data. Barthel index (BI) gains, BI efficiency, ADL independence at discharge (BI≧95), and discharge home were compared between patients who received an average of at least 1 unit of rehabilitation during hospitalization (high-provider group) and those who received less than 1 unit per day (low-provider group).Results: There were 4,145 patients in the high-provider group and 14,029 in the low-provider group. The high-provider group had higher BI gain and BI efficiency, as well as a higher percentage of patients with independent ADLs at discharge (41.6%) and a higher percentage of patients discharged home (79.2%). In multiple regression analysis, the high-provider group had higher BI gain (regression coefficient: 2.423) and BI efficiency (regression coefficient: 0.043). Multiple logistic regression analysis showed that the high-provider group had a higher rate of discharge home (odds ratio: 1.26) and a higher rate of ADL independence at discharge (odds ratio: 1.17).Conclusion: In patients with vertebral compression fractures, the amount of rehabilitation provision may have an impact on functional prognosis.
4.Effectiveness of a novel ex vivo training model for gastric endoscopic submucosal dissection training: a prospective observational study conducted at a single center in Japan
Takahito TOBA ; Tsuyoshi ISHII ; Nobuyuki SATO ; Akira NOGAMI ; Aya HOJO ; Ryo SHIMIZU ; Ai FUJIMOTO ; Takahisa MATSUDA
Clinical Endoscopy 2025;58(1):94-101
Background/Aims:
The efficacy of endoscopic submucosal dissection (ESD) for early-stage gastric cancer is well established. However, its acquisition is challenging owing to its complexity. In Japan, G-Master is a novel ex vivo gastric ESD training model. The effectiveness of training using G-Master is unknown. This study evaluated the efficacy of gastric ESD training using the G-Master to evaluate trainees’ learning curves and performance.
Methods:
Four trainees completed 30 ESD training sessions using the G-Master, and procedure time, resection area, resection completion, en-bloc resection requirement, and perforation occurrence were measured. Resection speed was the primary endpoint, and learning curves were evaluated using the Cumulative Sum (CUSUM) method.
Results:
All trainees completed the resection and en-bloc resection of the lesion without any intraoperative perforations. The learning curves covered three phases: initial growth, plateau, and late growth. The transition from phase 1 to phase 2 required a median of 10 sessions. Each trainee completed 30 training sessions in approximately 4 months.
Conclusions
Gastric ESD training using the G-Master is a simple, fast, and effective method for pre-ESD training in clinical practice. It is recommended that at least 10 training sessions be conducted.
5.Effectiveness of a novel ex vivo training model for gastric endoscopic submucosal dissection training: a prospective observational study conducted at a single center in Japan
Takahito TOBA ; Tsuyoshi ISHII ; Nobuyuki SATO ; Akira NOGAMI ; Aya HOJO ; Ryo SHIMIZU ; Ai FUJIMOTO ; Takahisa MATSUDA
Clinical Endoscopy 2025;58(1):94-101
Background/Aims:
The efficacy of endoscopic submucosal dissection (ESD) for early-stage gastric cancer is well established. However, its acquisition is challenging owing to its complexity. In Japan, G-Master is a novel ex vivo gastric ESD training model. The effectiveness of training using G-Master is unknown. This study evaluated the efficacy of gastric ESD training using the G-Master to evaluate trainees’ learning curves and performance.
Methods:
Four trainees completed 30 ESD training sessions using the G-Master, and procedure time, resection area, resection completion, en-bloc resection requirement, and perforation occurrence were measured. Resection speed was the primary endpoint, and learning curves were evaluated using the Cumulative Sum (CUSUM) method.
Results:
All trainees completed the resection and en-bloc resection of the lesion without any intraoperative perforations. The learning curves covered three phases: initial growth, plateau, and late growth. The transition from phase 1 to phase 2 required a median of 10 sessions. Each trainee completed 30 training sessions in approximately 4 months.
Conclusions
Gastric ESD training using the G-Master is a simple, fast, and effective method for pre-ESD training in clinical practice. It is recommended that at least 10 training sessions be conducted.
6.Correction: Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1–14 Years with Chronic Gastric Acid-Related Disease
Masaaki MORI ; Yoshiko NAKAYAMA ; Shigeo NISHIMATA ; Tadafumi YOKOYAMA ; Ryo MATSUOKA ; Reiko HATORI ; Masaki SHIMIZU ; Katsuhiro ARAI ; Yuri ETANI ; Tsuyoshi SOGO ; Tomoko ISHIZU ; Masahiro NII ; Ryosuke NAKASHIMA ; Toshiaki SHIMIZU
Pediatric Gastroenterology, Hepatology & Nutrition 2024;27(6):383-384
7.Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1–14 Years with Chronic Gastric Acid-Related Disease
Masaaki MORI ; Yoshiko NAKAYAMA ; Shigeo NISHIMATA ; Tadafumi YOKOYAMA ; Ryo MATSUOKA ; Reiko HATORI ; Masaki SHIMIZU ; Katsuhiro ARAI ; Yuri ETANI ; Tsuyoshi SOGO ; Tomoko ISHIZU ; Masahiro NII ; Ryosuke NAKASHIMA ; Toshiaki SHIMIZU
Pediatric Gastroenterology, Hepatology & Nutrition 2024;27(5):274-285
Purpose:
To evaluate prolonged esomeprazole use in Japanese pediatric patients for reflux esophagitis (RE) maintenance therapy and prevention of gastric (GU) and/or duodenal ulcers (DU) while using non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin (LDA).
Methods:
This multicenter, open-label, parallel-group, phase III study (NCT03553563) included patients who were administered esomeprazole according to body weight (10 mg/day [Groups 1 and 3] and up to 20 mg/day [Groups 2 and 4] for patients weighing 10–20 kg and ≥20 kg, respectively). Efficacy outcomes for Groups 1 and 2 (maintenance therapy for healed RE) and Groups 3 and 4 (prevention of long-term NSAID/LDA use-associated GU/DU) were the presence/absence of RE relapse and GU/DU recurrence, respectively.
Results:
Esomeprazole as maintenance therapy was associated with a low RE recurrence rate, independent of body weight or dosage. Recurrence rates of RE were 0.0% and 5.3% for Groups 1 and 2, respectively. In patients previously diagnosed with GU and/or DU due to long-term NSAID/LDA use, the recurrence rates of GU/DU during weeks 0–32 were 11.1% and 0.0% in Groups 3 and 4, respectively.
Conclusion
Long-term use of 10- or 20-mg, once-daily esomeprazole demonstrated a favorable benefit-risk balance in preventing RE and suppressing recurrence of GU and/or DU secondary to NSAID or LDA therapy in Japanese pediatric patients. No new safety concerns were identified. Esomeprazole may be a viable option for managing RE and preventing GU and DU in Japanese pediatric patients.
8.Correction: Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1–14 Years with Chronic Gastric Acid-Related Disease
Masaaki MORI ; Yoshiko NAKAYAMA ; Shigeo NISHIMATA ; Tadafumi YOKOYAMA ; Ryo MATSUOKA ; Reiko HATORI ; Masaki SHIMIZU ; Katsuhiro ARAI ; Yuri ETANI ; Tsuyoshi SOGO ; Tomoko ISHIZU ; Masahiro NII ; Ryosuke NAKASHIMA ; Toshiaki SHIMIZU
Pediatric Gastroenterology, Hepatology & Nutrition 2024;27(6):383-384
9.Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1–14 Years with Chronic Gastric Acid-Related Disease
Masaaki MORI ; Yoshiko NAKAYAMA ; Shigeo NISHIMATA ; Tadafumi YOKOYAMA ; Ryo MATSUOKA ; Reiko HATORI ; Masaki SHIMIZU ; Katsuhiro ARAI ; Yuri ETANI ; Tsuyoshi SOGO ; Tomoko ISHIZU ; Masahiro NII ; Ryosuke NAKASHIMA ; Toshiaki SHIMIZU
Pediatric Gastroenterology, Hepatology & Nutrition 2024;27(5):274-285
Purpose:
To evaluate prolonged esomeprazole use in Japanese pediatric patients for reflux esophagitis (RE) maintenance therapy and prevention of gastric (GU) and/or duodenal ulcers (DU) while using non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin (LDA).
Methods:
This multicenter, open-label, parallel-group, phase III study (NCT03553563) included patients who were administered esomeprazole according to body weight (10 mg/day [Groups 1 and 3] and up to 20 mg/day [Groups 2 and 4] for patients weighing 10–20 kg and ≥20 kg, respectively). Efficacy outcomes for Groups 1 and 2 (maintenance therapy for healed RE) and Groups 3 and 4 (prevention of long-term NSAID/LDA use-associated GU/DU) were the presence/absence of RE relapse and GU/DU recurrence, respectively.
Results:
Esomeprazole as maintenance therapy was associated with a low RE recurrence rate, independent of body weight or dosage. Recurrence rates of RE were 0.0% and 5.3% for Groups 1 and 2, respectively. In patients previously diagnosed with GU and/or DU due to long-term NSAID/LDA use, the recurrence rates of GU/DU during weeks 0–32 were 11.1% and 0.0% in Groups 3 and 4, respectively.
Conclusion
Long-term use of 10- or 20-mg, once-daily esomeprazole demonstrated a favorable benefit-risk balance in preventing RE and suppressing recurrence of GU and/or DU secondary to NSAID or LDA therapy in Japanese pediatric patients. No new safety concerns were identified. Esomeprazole may be a viable option for managing RE and preventing GU and DU in Japanese pediatric patients.
10.Correction: Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1–14 Years with Chronic Gastric Acid-Related Disease
Masaaki MORI ; Yoshiko NAKAYAMA ; Shigeo NISHIMATA ; Tadafumi YOKOYAMA ; Ryo MATSUOKA ; Reiko HATORI ; Masaki SHIMIZU ; Katsuhiro ARAI ; Yuri ETANI ; Tsuyoshi SOGO ; Tomoko ISHIZU ; Masahiro NII ; Ryosuke NAKASHIMA ; Toshiaki SHIMIZU
Pediatric Gastroenterology, Hepatology & Nutrition 2024;27(6):383-384


Result Analysis
Print
Save
E-mail